Filing Details

Accession Number:
0000921895-23-001593
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2023-06-28 16:14:32
Reporting Period:
2023-06-21
Accepted Time:
2023-06-28 16:14:32
Original Submission Date:
2023-06-23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
910267 Titan Pharmaceuticals Inc TTNP Biological Products, (No Disgnostic Substances) (2836) 943171940
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817604 Activist Investing Llc 1185 Avenue Of The Americas, 3Rd Floor.
New York NY 10036
No No No Yes
1932843 E. David Lazar Villa 1, 14-43Rd Street
Jumeirah 2
Dubai C0 00000
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Disposition 2023-06-21 3,388,902 $1.23 0 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2023-06-21 359,066 $1.23 0 No 4 S Indirect By Activist Investing LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Indirect By Activist Investing LLC
Footnotes
  1. These Shares were sold pursuant to a Share Transfer Agreement dated June 21, 2023. As consideration for the transfer, Mr. Lazar received $4,600,000.
  2. Prior to the filing of the Reporting Persons's Form 4 on June 23, 2023, the Reporting Person contacted the Issuer and advised the Issuer of his obligation to disgorge the "short-swing profit" realized by the Reporting Person, and that he was making preparation for payment of such disgorgement. Due to a ministerial error, such informaton was inadvertently excluded from the Form 4 filed by the Reporting Person on June 23, 2023.
  3. This Form 4 is filed jointly by Activist Investing LLC ("Activist Investing") and David E. Lazar (collectively, the "Reporting Persons").
  4. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or any other purpose.
  5. Securities of the Issuer beneficially owned directly by Activist Investing. Mr. Lazar, as the sole member and Chief Executive Officer of Activist Investing, may be deemed the beneficial owner of the securities of the Issuer beneficially owned by Activist Investing.